Amplyx

Elion Therapeutics

This biotechnology company develops antifungal medicines to prevent and treat life-threatening infections in immunocompromised patients, such as organ transplant and oncology recipients.

Amprologix

This biotechnology company develops novel antibiotics to treat antimicrobial-resistant bacterial infections for patients with conditions including MRSA and related skin and wound infections.

Bright Angel Therapeutics

This biotechnology company develops small molecule inhibitors to treat patients with drug-resistant and life-threatening fungal infections.

Chimerix

This biopharmaceutical company develops medicines for oncology and viral diseases for patients with life-threatening conditions.

Amphista Therapeutics

This company develops targeted protein degradation medicines to treat patients with cancer and other diseases.

Adagio Therapeutics

This biopharmaceutical company develops monoclonal antibody therapies for the prevention and treatment of viral respiratory diseases, primarily serving immunocompromised patients.

ReViral

This company develops antiviral therapeutics for respiratory syncytial virus to treat pediatric, immunocompromised and elderly patients.

F2G

This biopharmaceutical company develops novel antifungal therapies to treat patients with life-threatening rare and resistant fungal infections.